|
This section is about pharmaceutical business issues. Please submit your own professional article or your company press release. Every article is published with full credentials about Author. Please register to FarmavitaR+ and submit the content.
|
Understanding USP 71 Sterility Tests and Extended BUD
One of the most frequently asked questions recently asks how to extend the Beyond-Use Date (BUD) of compounded sterile preparations (CSPs). Eric S. Kastango, RPh, MBA, FASHP, reviewed the requirements of USP Chapter 797 necessary to complete in order to extend BUD. The use and limitation of sterility tests according to USP 71 was reviewed, along with process verification. Click here for recorded webinar.
Write comment (0 Comments)
|
|
|
|
More Articles...
|
|
|
| Page 1 of 24 |
regulanet®: Local representation for Global Regulatory Affairs
Pharmaceutical Licenesing and technology transfer
